Cyclosporin A--usefulness, risks and mechanism of action.
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D016026:Bone Marrow Transplantation; D003524:Cyclosporins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology; D008099:Liver / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008223:Lymphoma / Q000139:chemically induced / Q000276:immunology; D051379:Mice; D011948:Receptors, Antigen, T-Cell; D013601:T-Lymphocytes / Q000145:classification / Q000187:drug effects / Q000276:immunology
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011948:Receptors, Antigen, T-Cell